Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Axogen Reports Preliminary Q4 Revenue Of $42.7M, Up 18% Y/Y (Consensus $40.68M); Now Expects 2023 Revenue To Be At High End Of The $154M-$159M Guidance Range (Consensus $156.75M)

Author: Benzinga Newsdesk | January 04, 2024 05:49pm

Posted In: AXGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist